TP53 and liver cancer: Studies have shown that the p53 signaling pathway may be a potential biomarker and therapeutic target for HBV-related HCC [32], which helps us to diagnose and prevent the occurrence and recurrence of liver cancer early, thereby reducing surgery rates and healthcare costs.